Connection

LISA SATTER to Immunologic Deficiency Syndromes

This is a "connection" page, showing publications LISA SATTER has written about Immunologic Deficiency Syndromes.
Connection Strength

4.471
  1. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome. J Allergy Clin Immunol. 2023 04; 151(4):1081-1095.
    View in: PubMed
    Score: 0.679
  2. A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency. J Allergy Clin Immunol. 2019 06; 143(6):2296-2299.
    View in: PubMed
    Score: 0.527
  3. Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017 01; 139(1):232-245.
    View in: PubMed
    Score: 0.441
  4. Diagnostic Modalities in Primary Immunodeficiency. Clin Rev Allergy Immunol. 2022 Aug; 63(1):90-98.
    View in: PubMed
    Score: 0.326
  5. HSCT corrects primary immunodeficiency and immune dysregulation in patients with POMP-related autoinflammatory disease. Blood. 2021 11 11; 138(19):1896-1901.
    View in: PubMed
    Score: 0.319
  6. Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases. J Allergy Clin Immunol Pract. 2019 03; 7(3):761-773.
    View in: PubMed
    Score: 0.264
  7. The Impact of Immunodeficiency on NK Cell Maturation and Function. Curr Allergy Asthma Rep. 2019 01 19; 19(1):2.
    View in: PubMed
    Score: 0.262
  8. Mutations in PI3K110d cause impaired natural killer cell function partially rescued by rapamycin treatment. J Allergy Clin Immunol. 2018 08; 142(2):605-617.e7.
    View in: PubMed
    Score: 0.244
  9. Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease. J Clin Immunol. 2016 05; 36(4):377-387.
    View in: PubMed
    Score: 0.216
  10. Clinical, immunologic, and genetic characteristics of 148 patients with natural killer cell deficiency. J Allergy Clin Immunol. 2025 May; 155(5):1623-1634.
    View in: PubMed
    Score: 0.199
  11. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. J Allergy Clin Immunol. 2024 01; 153(1):230-242.
    View in: PubMed
    Score: 0.181
  12. The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. J Allergy Clin Immunol. 2023 02; 151(2):539-546.
    View in: PubMed
    Score: 0.171
  13. HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science. 2020 07 10; 369(6500):202-207.
    View in: PubMed
    Score: 0.145
  14. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J Allergy Clin Immunol. 2018 11; 142(5):1665-1669.
    View in: PubMed
    Score: 0.127
  15. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2018 06; 141(6):2142-2155.e5.
    View in: PubMed
    Score: 0.120
  16. Efficacy, Safety, and Pharmacokinetics of a New 10?% Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease. J Clin Immunol. 2016 08; 36(6):590-9.
    View in: PubMed
    Score: 0.110
  17. A novel Rab27a mutation binds melanophilin, but not Munc13-4, causing immunodeficiency without albinism. J Allergy Clin Immunol. 2016 08; 138(2):599-601.e3.
    View in: PubMed
    Score: 0.108
  18. Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome. Am J Hum Genet. 2018 06 07; 102(6):1126-1142.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.